Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 65 results for "tianjin medical university cancer ins..."

Experimental study on the regulation of erlotinib-induced radi...

1 Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, China 2 Tianjin Lung Cancer Center, ... Cancer Cell International, 3 weeks ago
Times of India

Disciplene centered options abroad

There is a varied set of choices for medical training overseas, as these two stories from the West and East show Medicine remains a dream career for many and some of the aspirants go abroad to train as doctors. While a majority look to countries ...
 Times of India1 month ago

AFCR Scientists Uncovered Potential New Treatment for Ovarian Cancer

(CancerConnect) A potential new treatment for ovarian cancer the most lethal cancer of the female reproductive system has recently been uncovered, thanks to research supported in part by the Asian Fund for Cancer Research (AFCR). AFCR-funded ...
 CancerConnect.com1 month ago

Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014

Research and Markets (http://www.researchandmarkets.com/research/k5mrz3/hand_foot_and) has announced the addition of the "" report to their offering. " provides data on the Hand, Foot And Mouth Disease clinical trial scenario. This report provides ...
 Individual.com1 week ago Research and Markets: Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014  TMC Net1 week ago RESEARCH AND MARKETS : Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014  4 Traders1 week ago
[x]  

Acetylon's Selective HDAC Inhibitors to be Featured in Multiple Presentations of Positive Clinical and Preclinical Data at the 56th ASH Annual Meeting and Exposition

Acetylon Pharmaceuticals, Inc. , the leader in the development of selective histone deacetylase (HDAC) inhibitors for enhanced therapeutic outcomes, today announced that ricolinostat, the Company's lead selective HDAC6 ...
 Industrial Info Financials3 weeks ago
[x]  
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - tianjin medical university cancer institute and hospital
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less